ReviewOncoTargets and therapy2019

MDM2 antagonists as a novel treatment option for acute myeloid leukemia: perspectives on the therapeutic potential of idasanutlin (RG7388).

Arushi Khurana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.